April 9, 2020
The Zacks Research Daily presents the best research results from our team of analysts. Today’s Research Daily presents new research reports on 16 main stocks, including Facebook (FB), JPMorgan Chase (JPM) and UnitedHealth Group (A H). These research reports were selected from the approximately 70 reports published by our team of analysts today.
You can see all today’s research reports here >>>
FacebookThe company’s shares have outperformed the S&P 500 in the past six months (-3.2% compared to -6.3%). Analyst Zacks believes Facebook is benefiting from the growth of Instagram stories and feeds and the growing user base in Asia-Pacific.
The launch of the Facebook View application, Facebook Pay, a simpler and faster Messenger application for iOS and a greater location control functionality for Android users is a positive point. Equities have outperformed the sector in the past year. However, Facebook expects ad sales to be affected by coronavirus blockages despite a significant spike in traffic.
In addition, growing limitations on tracking user activity amid growing privacy regulations and changes to mobile operating systems and browser platforms by Apple and Google, as well as tools such as that non-Facebook activity controls are expected to affect revenue growth. In addition, a persistent mix change to Stories should weigh on the ARPU.
(You can read the full research report on Facebook here >>>)
Actions of JP Morgan lost -10.5% in the past year against the 23.2% drop in the sector of large regional banks in Zacks. Zacks analyst believes that a decent loan application, the acquisition of InstaMed, new branch openings and a focus on credit card activities will continue to help the company’s financial position.
Its improved capital deployment plan reflects a solid balance sheet situation. The company notably stopped its share buybacks in order to use the capital for lending activities in a context of slowdown linked to coronaviruses. However, the accommodative monetary policy stance of the Federal Reserve is expected to hurt revenue growth in the short term.
Difficulties with expanding mortgage operations and the company’s high dependence on financial market revenues could to some extent hamper finances.
(You can read the full research report on JPMorgan here >>>)
UnitedHealthThe company’s shares have risen + 8.9% in the past three months against the -0.1% drop in the Zacks medical insurance sector. Zacks analyst says company revenue should continue to grow thanks to strong market position and attractive core business that continues to be boosted by new deals, renewed deals and expanding offerings Services.
UnitedHealth Group stands out in the industry for the health services, technology and innovations offered by its unit, Optum. Its numerous acquisitions have led to inorganic growth. The number of its members in the public and senior sector has grown steadily over the years and the trend is expected to continue.
Its solid balance sheet and its constant generation of cash flows make it possible to invest in business. The firm’s solid earnings forecasts instill investor confidence. The company is however experiencing a slowdown in its international operations.
(You can read the full research report on UnitedHealth here >>>)
Other notable reports that we are presenting today include the BHP group (BHP), Humana (HUM) and Cognizant Technology Solutions (CTSH).
The biggest technological breakthrough in a generation
Be among the first investors in the new type of device which, according to experts, could have an impact on society as much as the discovery of electricity. Current technology will soon be out of date and replaced by these new devices. In the process, it is expected to create 22 million jobs and generate $ 12.3 trillion in activity.
A few selected titles could skyrocket the most as deployment accelerates for this new technology. Early investors could see gains similar to that of buying Microsoft in the 1990s. Zacks’ special report, which has just been published, reveals 8 stocks to watch. The report is only available for a limited time.
See 8 revolutionary actions now >>
Note: Sheraz Mian heads the Zacks Equity Research department and is a renowned expert on aggregate income. He is frequently quoted in print and electronic media and publishes the weekly Earnings trends and Earnings overview reports. If you would like to receive an email notification every time Sheraz publishes a new article, please click here >>>
To read today
Extension of the user base, Instagram Strength Aids Facebook (FB)
Loan demand and new branches help JPMorgan (JPM) despite rate cuts
Solid UnitedHealth Service and Business Benefits (UNH)
The BHP group (BHP) is betting on the efficiency of its operations and its low prices
Zacks analyst believes that BHP’s efforts to make operations more efficient through a healthy balance sheet will drive growth despite falling metal prices.
Strong Medicare Company Helps Humana (HUM), High Costs Harm
According to analyst Zacks, his Medicare activity has produced solid results in recent years, which has led to significant growth.
Cognizant domain expertise (CTSH) stimulates growth prospects
According to analyst Zacks, Cognizant benefits from the domain’s expertise as well as its ability to exploit the digital transition underway in a context of strong competition.
Investments to strengthen the operational force of FirstEnergy (FE)
According to analyst Zacks, the modernization of FirstEnergy and long-term investments will increase the reliability of its service and lead to customer loyalty.
AIG focuses on revenue growth and cost control measures
According to analyst Zacks, streamlining activities by selling low-yield activities and focusing on high-growth companies generates revenue.
Yum China (YUMC) focuses on the digitization and innovation of menus
According to analyst Zacks, Yum China should benefit from an increased focus on menu innovation and digitization.
Best Buy (BBY) ‘Building the New Blue’ Program Bodes Well
Analyst Zacks says Best Buy’s “Building the New Blue” program should fuel growth.
Robust health care and FUJIFILM strategic buyout aids (FUJIY)
According to analyst Zacks, solid health activities as well as accretive acquisitions and investments in gene therapy are the engines of FUJIFILM’s growth prospects.
FLO Foods (FLO) ‘s higher earnings compared to a solid price / mix
According to analyst Zacks, Flowers Foods is progressing well with its effective pricing strategy. In particular, during the fourth quarter, the composition of prices contributed 2.1% to basic sales.
The PRA group (PRAA) continues to benefit from strategic efforts
According to Zacks analyst, the takeovers of eGov Systems and Canadian companies of Resurgent Holdings LLC allow the business to grow well.
Legal costs and low Linger client activity for Goldman (GS)
According to Zacks analyst, legal issues causing increased spending remain a concern for Goldman.
Robert Half International (RHI) struggling with high expenses
According to analyst Zacks, Robert Half’s bottom line is expected to remain tight as the company continues to see increases in staff pay and technology costs.
Low demand and higher costs to influence Apogee (APOG)
According to analyst Zacks, reduced customer demand due to the coronavirus epidemic as well as lower project volumes in the architectural glass segment will have an impact on Apogee’s results.
UnitedHealth Group Incorporated (UNH): free stock analysis report
JPMorgan Chase & Co. (JPM): Free stock analysis report
Humana Inc. (HUM): Free stock analysis report
Facebook, Inc. (FB): Free Stock Analysis Report
Cognizant Technology Solutions Corporation (CTSH): free stock analysis report
BHP Group Limited (BHP): Free stock analysis report
To read this article on Zacks.com, click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.